5/5/2017 KaloBiosPharmaceuticalsIncomeStatement(3YearGrowth)forDecember2016toDecember2012(KBIO)

Search DATA TOOLS SUPPORT PLANS kath7DaysRemaining

KaloBiosPharmaceuticals(KBIO) AddtoWatchlists CreateanAlert Notes(0)

SwitchTo Symbol Go
2.35 +0.03+1.29% OTCMarkets May5,20:00 Delayed15m USD

Quote FundamentalChart Technicals KeyStats Financials Data Estimates News Events YRatings Performance Valuation Multichart

IncomeStatement BalanceSheet CashFlow

Format(Quarterly,Annual,etc.)
3YearGrowth ExportData

Income(3YearGrowth) 201612 201512 201412 201312 201212

OperatingRevenue 86.46% 118.0%
Revenue 86.46% 118.0%
GrossProfit 86.46% 118.0%
GeneralandAdministrativeExpense 0.25% 41.36% 36.26% 18.93% 0.84%
SG&AExpense 0.25% 41.36% 36.26% 18.93% 0.84%
ResearchandDevelopmentExpense 31.59% 11.98% 12.81% 19.99% 2.36%
TotalOperatingExpenses 22.82% 5.11% 17.69% 19.77% 1.78%
NonOperatingInterestIncome 100.0% 12.97% 26.96%
NonOperatingInterestExpense 50.59% 66.02%
NonOperatingIncome 31.27%
OtherIncomeandExpenses 31.27%
ReconciledDepreciation 30.05% 13.46% 19.53% 29.29% 28.85%

BasicEPS(3YearGrowth) 201612 201512 201412 201312 201212

DilutedEPS(3YearGrowth) 201612 201512 201412 201312 201212

SharesData(3YearGrowth) 201612 201512 201412 201312 201212

AverageBasicSharesOutstanding 47.36% 150.6% 157.4% 143.1%
AverageDilutedSharesOutstanding 47.36% 150.6% 157.4% 143.1%

https://ycharts.com/financials/KBIO/income_statement/growth_3y 1/1